XBiotech Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
XBiotech Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • XBiotech Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15M, a 12.9% decline year-over-year.
  • XBiotech Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$42.9M, a 22.8% decline year-over-year.
  • XBiotech Inc. annual Operating Income (Loss) for 2023 was -$37.5M, a 8.76% decline from 2022.
  • XBiotech Inc. annual Operating Income (Loss) for 2022 was -$34.5M, a 37.5% decline from 2021.
  • XBiotech Inc. annual Operating Income (Loss) for 2021 was -$25.1M, a 37.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$37.5M -$3.02M -8.76% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$34.5M -$9.41M -37.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$25.1M -$6.81M -37.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$18.3M +$13M +41.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$31.2M -$10.2M -48.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 -$21M +$13.1M +38.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 -$34.1M +$18.7M +35.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 -$52.8M -$15.3M -40.7% Jan 1, 2016 Dec 31, 2016 10-K/A 2019-03-15
2015 -$37.5M -$15.7M -72.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 -$21.8M -$11.9M -119% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 -$9.93M Jan 1, 2013 Dec 31, 2013 10-K/A 2016-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.